Company: FWDI
Filing Date: 2025-06-10
Form Type: PRE 14A
Source: 0001683168-25-004370
Chunk: 12

Company: Forward Industries, Inc.
Filing Date: 2025-06-10
Form: PRE 14A
Chunk 12
---
 leadership roles at the National Institutes of Health and Department of State
from 1992 to 2012; and inaugural president of the Global Virus Network, a 501c3 from 2012 to 2015. Dr. Hrynkow, a neuroscientist,
is an elected member of the Council on Foreign Relations and an elected Fellow of the American Association for the Advancement of Science.
She advises a range of non-profit organizations on science and health matters, including the National Academies of Sciences, Engineering
and Medicine. She has served as an appointee to the President’s Council of Advisors on Science and Technology.

Keith Johnson. Mr. Johnson has been a
director of the Company since May 2025. Since May 2023, Mr. Johnson has been the interim Chief Financial Officer of Amaze Holdings
Inc. (NYSE American: AMZE), an e-commerce wine product company. Beginning until May 2023, Mr. Johnson provided consulting and
accounting services to several companies on a contract basis. Prior to that, Mr. Johnson served as Chief Financial Officer of
Watertech Equipment & Sales, a startup company formed to develop biological pathogen reduction technologies from October
2014 until December 2020. Since April 2020, Mr. Johnson has served on the board of directors of Amergent Hospitality
Group Inc. (“Amergent”) and as chairman of its audit committee and a member of its compensation committee. Mr.
Johnson was selected as a director because of his board experience and his strong accounting background.

| 8 |

Executive Officers of Forward Industries, Inc.

| Name              | Age | Position                        | Appointed |
| Michael Pruitt    |  65 | Interim Chief Executive Officer | May 2025  |
| Kathleen Weisberg |  54 | Chief Financial Officer         | July 2023 |

Michael Pruitt. Mr. Pruitt was appointed interim Chief Executive Officer on May 16, 2025. Mr. Pruitt also served on the Board from January 28, 2025 to May 16, 2025. Mr. Pruitt founded Avenel Financial Group, a boutique financial services firm concentrating on emerging technology company investments in 1999. In 2001, Mr. Pruitt formed Avenel Ventures, a technology investment and private venture capital firm. In February 2005, Mr. Pruitt formed Chanticleer Holdings, Inc., then a public holding company (now known as Sonnet BioTherapeutics Holdings, Inc